Cargando…
Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma
IMPORTANCE: Brain metastasis (BrM) in gastroesophageal adenocarcinoma (GEA) is a rare and poorly understood phenomenon associated with poor prognosis. OBJECTIVES: To examine the clinical and genomic features of patients with BrM from GEA and evaluate factors associated with survival. DESIGN, SETTING...
Autores principales: | Tsai, Charlton, Nguyen, Bastien, Luthra, Anisha, Chou, Joanne F., Feder, Lara, Tang, Laura H., Strong, Vivian E., Molena, Daniela, Jones, David R., Coit, Daniel G., Ilson, David H., Ku, Geoffrey Y., Cowzer, Darren, Cadley, John, Capanu, Marinela, Schultz, Nikolaus, Beal, Kathryn, Moss, Nelson S., Janjigian, Yelena Y., Maron, Steven B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403772/ https://www.ncbi.nlm.nih.gov/pubmed/36001319 http://dx.doi.org/10.1001/jamanetworkopen.2022.28083 |
Ejemplares similares
-
Perioperative versus total neoadjuvant chemotherapy in gastric cancer
por: Yang, Jessica, et al.
Publicado: (2023) -
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer
por: Janjigian, Yelena Y., et al.
Publicado: (2015) -
Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer
por: Ku, Geoffrey Y., et al.
Publicado: (2021) -
Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
por: Magahis, Patrick T, et al.
Publicado: (2023) -
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications
por: El Jabbour, Tony, et al.
Publicado: (2022)